TerminatedNCT02942368
Adaptive tDCS for Treatment-Resistant MDD
Device studyAges 18–65United StatesDepression
Understand this study
Who could participate?
Listed age limits: 18 years to 65 years.
- Listed locations
- St LouisSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: April 14, 2017
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 5
- Sponsor
- Washington University School of Medicine
- Sponsor type
- University
- Study type
- Device
- Intervention type
- DEVICE
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT02942368
- Official title
Show the full official title
Adaptive Transcranial Direct Current Stimulation as an Adjunctive Therapy for Treatment-Resistant Major Depressive Disorder
Recruitment & locations
TerminatedSt Louis
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is Washington University School of Medicine, a university.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as terminated.
